Downloads: 3 | Views: 44 | Weekly Hits: ⮙3 | Monthly Hits: ⮙3

Research Paper | Cancer Science | India | Volume 13 Issue 2, February 2024

Fluorescence Kinematics: An Innovative & Promising Tool for the Diagnosis & Treatment Monitoring of Malignancy in Early Stage

Priya Sachin Deole | Nachiket Sachin Deole

Abstract: For many cancers, early detection is the key for improving survival and reducing the morbidity associated with radical resections due to late presentation. Detection requests specific recognition, the advent of fluorescence imaging (FI) for cancer cell detection in the field of oncology is promising for both cancer screening and surgical resection. early detection is the cornerstone for improving outcomes and reducing cancer - related morbidity and mortality. Tumor markers have to be ideally present on the surface of cancer cells. Their targeting with ligands coupled to imaging agents make them visible/detectable. While the establishment brags that more cancer patients survive than ever before, the horrific side effects inflicted by conventional therapy often leave patients partially or severely debilitated, and set the stage for deadly secondary diseases. For those patient suffering from cancer the dangerous mix of chemotherapy and surgery not only failed to cure the cancer, but destroyed their remaining quality of life. The laser treatment has the potential to destroy the malignant cells in primary stage. This unique treatment can also seek and destroy cancer cells that have spread (metastasized) from the original tumor to other parts of the body. This is especially critical as metastasized cells are the primary cause of cancer death. A laser beam operating in the "near - infrared frequency of light. This beam heats tissue to a depth of several centimeters, allowing the beam to penetrate directly into a solid tumor with minimal damage to normal tissue because it can be focused directly through intact skin, no surgical incision is required. Fluorescence lifetime imaging (FLIM) is a novel imaging technique that generates image contrast between different states of tissue due to differences in fluorescence decay rates. presented fluorescence diagnostic system in combination with new fluorescent probes has the potential to distinguish between cancerous tissue samples with high enzymatic activity and non - cancerous tissue samples with lower enzymatic activity.

Keywords: health, surgery, chemotherapy, laser

Edition: Volume 13 Issue 2, February 2024,

Pages: 1760 - 1765